DEEPEXI TECH (01384) FY2025: Revenue Jumps 70.8% to RMB414.99 Million as Net Loss Narrows 25.5%

Bulletin Express03-20

Hong Kong – Deepexi Technology Co., Ltd. (“DEEPEXI TECH”, HKEX: 01384) reported FY2025 results for the year ended 31 December 2025, marking its first post-listing annual disclosure since debuting on the Main Board in October 2025.

Revenue and Gross Profit • Consolidated revenue surged 70.8% year on year to RMB414.99 million, driven by robust demand for AI solutions. • Gross profit rose 81.1% to RMB228.56 million, pushing gross margin up 3.2 percentage points to 55.1%.

Business Mix Shift Toward AI Solutions • FastAGI enterprise AI solution revenue expanded 181.5% to RMB254.47 million, now contributing 61.3% of total sales (2024: 37.2%). • FastData enterprise data intelligence solution revenue edged up 5.2% to RMB160.53 million, representing 38.7% of group turnover. • Customer base grew 46.1% to 130 enterprises, with FastAGI customers tripling from 20 to 70.

Profitability and Non-HKFRS Measure • Statutory loss and total comprehensive loss narrowed 25.5% to RMB934.56 million (2024: RMB1.25 billion), aided by a 36.4% reduction in fair-value losses on preferred share liabilities to RMB735.15 million. • Adjusted net loss (non-HKFRS) contracted 71.4% to RMB27.54 million after adding back RMB115.26 million share-based payments, RMB735.15 million fair-value changes on preferred shares and RMB56.62 million listing expenses.

Operating Expenses • Selling & marketing costs rose 18.5% to RMB105.58 million, reflecting higher headcount and travel outlays. • Administrative expenses jumped 330.3% to RMB212.20 million, mainly due to share-based payments and IPO-related fees. • R&D spending increased 32.3% to RMB107.71 million, aligned with intensified investment in large-model training and solution testing.

Cash Flow and Balance Sheet • Net cash outflow from operations widened to RMB198.90 million (2024: outflow of RMB117.72 million). • Cash and cash equivalents expanded to RMB686.34 million (31 Dec 2024: RMB208.32 million), boosted by HK$657.28 million (approximately RMB599.64 million) net IPO proceeds. • Interest-bearing bank borrowings stood at RMB60.89 million; all are short-term and RMB-denominated. • Net current assets reached RMB813.09 million, versus a RMB3.69 billion deficit a year earlier. Total equity turned positive at RMB829.84 million (31 Dec 2024: negative RMB3.68 billion). • Gearing ratio dropped sharply to 23.4% from 965.3% after conversion of preferred shares and fresh equity capital.

Segment & Operational Metrics • Inventories decreased 32.9% to RMB9.76 million as project deliveries accelerated. • Trade and bills receivables rose 85.0% to RMB307.61 million, reflecting higher sales; impairment provisions remained stable at RMB18.94 million. • Trade and bills payables climbed 33.6% to RMB111.70 million, mirroring increased procurement volumes.

Capital Expenditure and Commitments • FY2025 capex totaled RMB5.70 million, mainly for computing infrastructure and office upgrades. • No significant capital commitments, acquisitions or disposals were reported during the period.

Dividend and Outlook The Board did not recommend a dividend for FY2025. Management reiterated plans to channel IPO proceeds into R&D (40%), domestic sales expansion (30%), overseas growth (15%), M&A opportunities (5%) and general working capital (10%), with utilisation expected by end-2030.

DEEPEXI TECH aims to advance its Deepexi enterprise large model, enhance data-model-application engineering capabilities and deepen industry integration to capture ongoing AI-driven digital transformation opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment